Evoke Pharma (EVOK) Misses Q3 EPS by 14c

Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.34), $0.14 worse than the analyst estimate of ($0.20).

As of September 30, 2017, our cash and cash equivalents were approximately $10.4 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• The Gap, Inc. (GAP) Tops Q2 EPS by 3c
• SentinelOne, Inc. (S) Tops Q2 EPS by 1c; offers guidance
• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance